- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Allergan Inc/United States
+ Add to WatchlistAGN:US
101.4100 USD 0.9900 0.99%As of 20:04:04 ET on 05/17/2013.
Snapshot for Allergan Inc/United States (AGN)
| Open: | 100.5600 | Day's Range: | 99.6200 - 101.4300 | Volume: | 2,568,091 |
|---|---|---|---|---|---|
| Previous Close: | 100.4200 | 52wk Range: | 81.2800 - 116.4500 | 1-Yr Rtn: | +14.47% |
Key Statistics for AGN
| Current P/E Ratio (ttm) | 25.1120 |
|---|---|
| Estimated P/E(12/2013) | 21.3360 |
| Relative P/E vs. SPX | 1.5391 |
| Earnings Per Share (USD) (ttm) | 4.0383 |
| Est. EPS (USD) (12/2013) | 4.7530 |
| Est. PEG Ratio | 1.5647 |
| Market Cap (M USD) | 30,057.97 |
| Shares Outstanding (M) | 296.40 |
| 30 Day Average Volume | 2,230,095 |
| Price/Book (mrq) | 5.6295 |
| Price/Sale (ttm) | 5.1795 |
| Dividend Indicated Gross Yield | 0.20% |
| Cash Dividend (USD) | 0.0500 |
| Last Dividend | 05/21/2013 |
| 5 Year Dividend Growth | 0.00% |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AGN
Company Profile & Key Executives for AGN
Allergan, Inc. is a multi-specialty health care company that develops and commercializes pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets globally.
| David E I PyottChairman/President/CEO | Jeffrey L EdwardsExec VP:Finance & Business/CFO |
| Scott M WhitcupExec VP:Research & Dev | Douglas S IngramExec VP/Pres:Europe & Africa |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AGN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page